Amoxicillin/clavulanic acid, also known as co-amoxiclav or amox-clav, sold under the brand name Augmentin, among others, is an antibiotic medication used for the treatment of a number of bacterial infections. It is a combination consisting of amoxicillin, a β-lactam antibiotic, and potassium clavulanate, a β-lactamase inhibitor. It is specifically used for otitis media, streptococcal pharyngitis, pneumonia, cellulitis, urinary tract infections, and animal bites. It is taken by mouth or by injection into a vein.Common side effects include diarrhea, vomiting, and allergic reactions. It also increases the risk of yeast infections, headaches, and blood clotting problems. It is not recommended in people with a history of a penicillin allergy. It is relatively safe for use during pregnancy.Amoxicillin/clavulanic acid was approved for medical use in the United States in 1984. It is on the World Health Organizations List of Essential Medicines. The World Health Organization classifies amoxicillin/clavulanic-acid as critically important for human medicine. It is available as a generic medication. In 2019, it was the 93rd most commonly prescribed medication in the United States, with more than 8 million prescriptions. Medical uses
Amoxicillin/clavulanic acid is widely used to treat or prevent many infections caused by susceptible bacteria, such as:

urinary tract infections
respiratory tract infections
skin and soft tissue infections
sinus infections
tonsillitis
cat scratches
infections caused by the bacterial flora of the mouth, such as:
dental infections
infected animal bites
infected human bites (including uncomplicated "clenched-fist" or "reverse-bite" injuries)It is also used for tuberculosis that is resistant to other treatments.
In some fetuses, this process does not occur completely between all fingers or toes and some residual webbing remains. Genetics
Five types of syndactyly have been identified in humans. The corresponding loci associated with these types and their common phenotypical expression are as follows:

type I:  2q34-q36; webbing occurs between middle and ring fingers and/or second and third toes. type II:  2q31; also involves long and ring fingers, but has a sixth finger merged in between. type III:  6q21-q23; small finger is merged into the ring finger. type IV:  7q36; involves all fingers and/or toes. type V:  2q31-q32; similar to type I, but the metacarpals and metatarsals may also be fused. Management
Syndactyly of the border digits (thumb/index finger or ring/small fingers) is treated at early age to prevent the larger digit from curving towards the smaller digit with growth. Typically, syndactyly of these digits is treated at six months of age. The treatment of syndactyly of the other digits is elective and is more commonly performed when the digits have grown, at 18–24 months of age. Techniques
Because the circumference of the conjoined fingers is smaller than the circumference of the two separated fingers, there is not enough skin to cover both digits once they are separated at the time of surgery. Therefore, the surgeon must bring new skin into the area at the time of surgery. This is most commonly done with a skin graft (from groin or anterior elbow).